Infancy to Toddlerhood: Early Nutrition & Tolerance Study
A fully digital trial to evaluate the ability to protect against food allergies with routine feeding of the most common food allergy proteins during infancy and toddlerhood.
Be among the first to receive an invitation to get started:
About The INTENT Study
The study will explore how parents feed their infants, how they feel about introducing common allergens, and how they keep their babies tolerant to the most common food allergens over time. Parents who join the study will also receive educational content from pediatricians and dieticians through the mobile application.
The study is sponsored by Before Brands, Inc., a food allergy and wellness company, in partnership with the Duke Clinical Research Institute.
A Virtual Study
The entire study will live on the mobile application and no study-related clinic visits are required. On the mobile application, parents will be able to access all questionnaires and access exclusive education content to guide parents through first feeding in infancy to toddlerhood from leading pediatrics, dieticians, and allergists.
The study will last approximately 18 months as the child grows from infancy to toddlerhood. Many of the experts guiding the study are also food allergy parents.
Study Activities
Half of the parents will be sent monthly supplies of a commercially available food product that contains peanuts, tree nuts, milk, fish, egg, shellfish, soy, grains, and sesame and asked to complete questionnaires directly on the mobile application. The other half of the parents will simply feed their child as they normally would and complete questionnaires directly on the mobile application.
Sign Up
We’re planning to enroll starting in December 2020 and will continue to enroll babies until the study fills throughout 2021.
We will enroll babies who are 4-6 months of age at the time of enrollment*.
Be among the first to receive an invitation to get started.
*Other eligibility participation requirements will apply and will be available on the mobile application.
Study Partners
Our Team
Before Brands, Inc. and Duke Clinical Research Institute have teamed up with experts around the country to design and implement a fully digital pediatric allergy study.
The Executive Advisory Committee brings together leading experts in their fields, including pediatric allergy, epidemiology, clinical research, digital health design, and pediatric nutrition. The committee will provide scientific guidance on the study design, execution, analysis, and digital design of the INTENT Study.
Principal Investigators
David Jeong, MD
Principal Investigator
Pediatrician and Allergist
Section Head, Virginia Mason Medical Center and Benaroya Research Institute
Food Allergy Dad
Christoph Hornik, MD, PhD
Duke Clinical Research Institute Principal Investigator
Assoc. Professor, Duke University
Chief, Division of Quantitative Sciences
Executive Advisory Committee
Drew Bird, MD
Director of the Food and Allergy Center at Children's Medical Center
Associate Professor, UT Southwestern Medical Center
Ruchi Gupta, MD, MPH
Director, Institute for Public Health and Medicine (IPHAM) - Center for Food Allergy & Asthma
Professor, Northwestern University School of Medicine
Food Allergy Mom
Susannah Fox
Healthcare and information technology researcher
Chief Technology Officer, US Department of Health and Human Services (2015-17)
Food Allergy Mom
Kari Nadeau, MD, PhD
SpoonfulOne Co-Founder
Director, Sean N. Parker Center for Allergy and Asthma Research at Stanford University
Endowed Professor, Stanford University School of Medicine
Edwin Kim, MD, MS
Study Consultant for DCRI
Director, UNC Food Allergy Initiative
Associate Professor, UNC
Food Allergy Dad
Carina Venter, PhD, RD
Chair, International Network of Dietitians and Nutritionists in Allergy
Associate Professor of Pediatric Allergy & Immunology at the University of Colorado School of Medicine
Dave Stukus, MD
Director, Food Allergy Treatment Center at Nationwide Children's Hospital
Associate Professor, Nationwide Children's Hospital and The Ohio State University College of Medicine
Before Brands Team
Wendy Sue Swanson, MD, MBE
Chief Medical Officer
Pediatrician
Alex Wei, PharmD
Medical Director
Jimmy Xu, PharmD
Manager, Medical and Digital Health
Be among the first to receive an invitation to get started
The trial is expected to begin enrollment in December 2020 and will continue to enroll babies until the study fills throughout 2021.
We will enroll babies who are 4-6 months of age at the time of enrollment*.
Be among the first to receive an invitation to get started.
*Other eligibility participation requirements will apply and will be available on the mobile application.